Drugmakers

The government is likely to revise the Uniform Code of Pharmaceutical Marketing Practices in 2023. 

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

An important supplier of generic drugs to the world, Indian companies procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China.

Drugmakers raise 2018 US prices, stick to self-imposed limits

Soaring U.S. prices for both branded and generic drugs have sparked public outrage and government investigations over the past few years.

Drugmakers in Davos shift focus to chronic diseases of poor

Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.

Indian drug cos have begun to adjust to FDA norms: Intas Pharma

The country‘s pharma sector plagued by several issues including regulatory and pricing pressure underperformed Nifty losing nearly 14-15 percent in 2016. US-based drugmakers could see a pricing pressure of 10 percent in 2017 as well, according to Intas Pharmaceuticals.

Donald Trump vows to bring down drug prices, doesn't say how

The Republican US president-elect, a wealthy real estate developer who ran a campaign with a populist appeal, did not state in the interview how he would reduce the cost of prescription drugs. Trump previously has suggested he was open to allowing importation of cheaper medicines from overseas.

Stop trying to defend huge price hikes: GSK CEO to drugmakers

Drug prices have come under scrutiny in recent months after Mylan received public backlash for the sharp price increases the Epipen, an injection device to treat fatal anaphylactic shocks from food allergies or insect bites. The price of a two-pack Epipen has risen to nearly USD 600, from just USD 100 in 2007.

India agreed to not issue compulsory drug licenses: US industry

The comments were revealed in a submission last month by the US-India Business Council to the US Trade Representative, which is reviewing global intellectual property laws for an annual report identifying trade barriers to US companies.

Will serve Indian market as much as possible: Merck

Merck is also adding newer products to cater to the growing demand of the Indian market, which is also one of the fastest growing markets for the company.

Indian drugmakers see US sales hit by delay in new nods

India's USD 15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about production processes, supplies about 40 percent of generic and over-the-counter drugs to the United States.

EU fines Ranbaxy, others for blocking cheaper drugs

EU antitrust regulators fined nine drugmakers a total of 146 million euros on Wednesday for blocking the supply of cheaper medicines on the market, with a penalty of 94 million euros imposed on Denmark's Lundbeck .

Drugmakers fall on government price control policy

The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November.

Ind-Swift, Wockhardt launch generic Lipitor in UK

Drugmakers Ind-Swift and Wockhardt have jointly launched a generic version of Pfizer's cholesterol lowering drug Lipitor in the United Kingdom, the two companies said.

India drugs inquiry could prompt new US scrutiny

Global drugmakers could face new US scrutiny after a report from lawmakers in India alleged abuses in that country's drug approval process, lawyers familiar with such investigations said.

Pharma firms want tax cuts, R&D sops boost

Drugmakers want tax exemption deadline for export oriented unit (EOUs) to be extended and want infrastructure or priority sector status in the budget on Feb 28.